Peer-influenced content. Sources you trust. No registration required. This is HCN.

Journal of Clinical OncologyDiffuse Large B-Cell Lymphoma’s New Genomics: The Bridge and the Chasm

How can oncologists successfully implement precision medicine strategies in diffuse large B-cell lymphoma (DLBCL)? In this review, the authors describe the recently proposed genomic categories of DLBCL and their potential use for personalized treatment, as well as the significant challenges they will present.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form